Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2023 Earnings Call Transcript

Operator: Hello and thank you for standing by. My name is Andrew and I will be your conference operator today.

Related Keywords

Wuxi ,Jiangsu ,China ,Australia ,Canada ,United States ,Australian ,Friedrich Finckenstein ,Michael Yee ,Jim Ziegler ,Fred Vogt ,Jean Marc Bellemin ,Sara Pellegrino ,Igor Bilinsky ,Peter Lawson ,Barclays ,Roofing Companies ,Iovance Biotherapeutics Inc ,Corporate Communications ,Nasdaq ,Call Transcript May ,Results Conference ,Senior Vice President ,Investor Relations ,Interim President ,Chief Executive Officer ,Chief Operating Officer ,Executive Vice President ,Chief Medical Officer ,Chief Financial ,Aviraj Puri ,Regulatory Strategy ,Translational Medicine ,Biologics License Application ,Nowi D ,Marc Bellemin ,Cancer Treatment ,Bioresearch Monitoring ,